The BrainSense adaptive deep brain stimulation system personalizes therapy by dynamically adjusting stimulation based on real ...

Vaxitek HVT+IBD+H5 integrates COBRA technology to address the ongoing viral evolution challenges of avian influenza, as well ...

Biopharmas and global agencies are now prioritizing initiatives and innovations to drive speed across product development ...

Unconfirmed reports suggest that a popular flu vaccine educational campaign has come to an end.

John Arena, interim president of global pharma services at Cencora, discusses the importance of engaging with partners as ...

According to ZERO Prostate Cancer, Novartis has committed $7.5 million to the initiative.

Traditional approaches to HCP segmentation are no longer sufficient. The challenge now is to maintain personalization at ...

Valencia will seek to leverage the investment as well as Surek’s leadership experience to drive commercialization of its ...

The campaign is based on the results of a survey that reveals the experiences of patients and caregivers in their communities ...

Led by Bosch Ventures, Applyo Jena’s Series A funding seeks to accelerate the development and commercialization of its ...

Under terms of the deal, Stoke will spearhead global development of zorevunersen, while Biogen will receive exclusive rights ...

Ospomyv, a biosimilar to Prolia, is indicated for postmenopausal women and men at high risk of fracture, while Xbryk, a ...